Date: Friday, April 23, 2010

Time: 8:00 AM – 4:30 PM

Place: John Theurer Cancer Center at Hackensack University Medical Center
The Hekemian Conference Center Auditorium
30 Prospect Avenue
Hackensack, NJ 07601

Cost: Registration, breakfast and lunch are complimentary.

If you have any questions, please contact Jessie Vicioso, 201-996-5931, rvicioso@humed.com

Program Features:

• Mulltiple Myeloma: A Changing Landscape
  Ken Anderson, MD • Dana Farber Cancer Center
   
• Non-Myeloablative Transplants: Expanding the Field, New Strategies to Improve Outcome
  Frederick R. Appelbaum, MD • Fred Hutchinson Cancer Research Center
   
• Diffuse Large Cell Lymphoma: Can We Stratify Patients Beyond the R-CHOP Era?
  James Armitage, MD • University of Nebraska Medical Center
   
• Indolent Lymphomas: Changing Perspectives; What is the Best Sequence Among All Options Available?
  Thomas Witzig, MD • Mayo Clinic
   
• Hodgkin Lymphoma: ABVD Does Not Fit All
  Volker Diehl, MD • German Hodgkin Study Group – University of Cologne
   
• T-cell Lymphomas: Still a Very Challenging Disease
  Steven Rosen, MD • Robert H. Lurie Comprehensive Cancer Center
   
• Acute Myeloid Leukemias: The Impact of Molecular Stratification
  Martin Tallman, MD • Robert H. Lurie Comprehensive Cancer Center
   
• Adjusting to the Changing Environment of Health Care
  Kip Piper, MA, FACHE, President Health Results Group, LLC

Purpose: This program is designed to provide physicians with a review of current and innovative patient care options, novel therapies through clinical trials and emerging concepts in the management of hematological malignancies.

Objectives: At the conclusion of this learning activity the participant will be able to:

• Identify the rapid changes in the management of multiple myeloma
• Review the biology of large B-cell lymphoma and its impact on treatment approaches
• Recognize the new prognostic markers beyond IPI and FLIPI and new approaches in low grade lymphoma
• Examine new classification in T-cell lymphoma and emerging strategies
• Improve treatment/stratification of patients with early versus advanced stage Hodgkin Disease
• Introduce more advance use of PET scan imaging in lymphomas and its use for managing patients
• Appreciate emerging molecular stratification of both lymphoid and myeloid malignancies
• Learn new trends in both autologous and allogenic stem cell transplantation objectives

Credit: Hackensack University Medical Center is accredited by the Medical Society of New Jersey to sponsor continuing medical education for physicians. Hackensack University Medical Center designates this educational activity for 6.5 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.